CJC-1295 research guide

CJC-1295 in Eichen — GHRH Analog Research Guide

CJC-1295 research guide for Eichen. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

Research-Grade CJC-1295 for Eichen Investigators

The pursuit for CJC-1295 in Eichen inevitably reaches the same conclusion: research peptides are sourced from specialist online vendors, not brick-and-mortar outlets. The key implication for Eichen researchers: sourcing CJC-1295 comes down completely to vendor quality evaluation, not geography — and the framework for evaluating that quality is identical for researchers everywhere. What consistently distinguishes top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for contamination assurance. Use this guide to evaluate CJC-1295 vendors rigorously — the quality evaluation approach outlined here work regardless of your location.

CJC-1295: What the Research Shows

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Eichen researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

CJC-1295 Purchasing Guide

Before assessing any particular supplier, understand what genuine quality documentation contains — so you can identify whether a supplier meets the standard. The HPLC analytical chromatogram is the most important document in the COA: it should show a large primary peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be stated as ≥98%. For Eichen researchers evaluating vendors with limited track records: a test quantity before committing to research volumes before placing larger orders is the accepted approach among experienced researchers. Hold lyophilised CJC-1295 at minus 20 degrees Celsius until ready to use; reconstitute only the quantity required for your immediate research and keep the remainder frozen.

Order CJC-1295 — ships to Eichen
COA-verified · International tracking · Research grade
Order Now →

CJC-1295 Research Safety Guide

As a research compound, CJC-1295 has not been through the clinical trial process required for pharmaceutical approval — its safety profile is characterised by preclinical data and restricted human research data. Lyophilised CJC-1295 should be frozen at −20°C as soon as it arrives; do not freeze and thaw reconstituted CJC-1295 multiple times by aliquoting into single-use portions. Bacterial endotoxin contamination is the primary safety concern unique to this class of compound — verify endotoxin testing is documented in your batch COA before any injectable research application. The research literature on CJC-1295 should be studied thoroughly before designing any protocol — study designs, dosing ranges, and outcome measures vary significantly and conclusions do not uniformly extrapolate.

Frequently Asked Questions

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →